Our site may be slower due to heavy traffic from automated "bots" and AI crawlers. We're working to fix this.

Anupama Kumar, MD

Title(s)Assistant Professor, Medicine
SchoolSchool of Medicine
Address400 Parnassus Avenue, #A444
San Francisco CA 94143
vCardDownload vCard

    Collapse Biography 
    Collapse education and training
    Tufts University School of MedicineM.D.
    Tufts Medical CenterInternal Medicine Residency
    University of California, San DiegoHematology/Oncology Fellowship

    Collapse Overview 
    Collapse overview
    Dr. Kumar is hematologist/oncologist who specializes in taking care of patients with hematological malignancies. She completed medical school training and residency at Tufts Medical Center, and hematology/oncology fellowship at University of California, San Diego. She received specialized training through the bone marrow transplant track during her final year of fellowship. Her clinical focus at University of California, San Francisco is multiple myeloma. She takes care of patients in clinic and in the hospital. She leads clinical trials enrolling patients with multiple myeloma.

    Collapse ORNG Applications 
    Collapse Clinical Trials

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.
    Newest   |   Oldest   |   Most Cited   |   Most Discussed   |   Timeline   |   Field Summary   |   Plain Text
    Altmetrics Details PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Structure-guided engineering of CCL27 enhances natural ligand CAR T-cells against CCR10 for multiple myeloma. bioRxiv. 2025 Aug 23. Chilakapati N, Patiño-Escobar B, Chen EY, Dalal R, de Montagnac J, Johnson H, Kang AS, Akagi N, Ramos E, Phojanakong P, Salangsang F, Zeng Y, Chari A, Chung A, Kumar AD, Martin TG, Wolf JL, Shy BR, Steri V, Karlon WJ, Kortemme T, Barwick BG, Wiita AP. PMID: 40894691; PMCID: PMC12393364.
      View in: PubMed   Mentions:
    2. Sequential Targeting in Multiple Myeloma: Talquetamab, a GPRC5D bispecific antibody, as a Bridge to BCMA CAR-T cell therapy. Blood. 2025 Aug 01. Dhakal B, Akhtar OS, Fandrei D, Jensen A, Banerjee R, Pan D, Richard S, Friend R, Rees MJ, Costello P, Vazquez Martinez MA, Pasvolsky O, Wagner CB, Davis JA, Castaneda Puglianini OA, Reshef R, Afrough A, Dima D, Bhutani M, Nadeem O, Parrondo RD, Freeman CL, Mikkilineni L, Raza S, Anderson LD, Kapoor P, Hosoya H, Chhabra S, Grajales-Cruz A, Gaballa MR, Midha S, Alsina M, Sborov DW, Patel KK, Lin Y, Ferreri CJ, Gagelmann N, Kumar AD, Hansen DK, Cowan AJ, Costa LJ, Merz M, Sidana S. PMID: 40749169.
      View in: PubMed   Mentions: 1     Fields:    
    3. Emerging GPRC5D-Targeted therapies for multiple myeloma: a comprehensive review. Expert Opin Investig Drugs. 2025 May; 34(5):379-389. Pan D, Kumar A, Lipof JJ, Chung A, Wolf JL, Martin TG, Arora S, Sayre PH, Chari A. PMID: 40425184.
      View in: PubMed   Mentions:    Fields:    Translation:HumansAnimals
    4. Targeting high-risk multiple myeloma genotypes with optimized anti-CD70 CAR-T cells. Blood. 2025 May 13. Kasap C, Izgutdina A, Patiño-Escobar B, Kang AS, Chilakapati N, Akagi N, Manoj AM, Johnson H, Rashid T, Werner J, Barpanda A, Geng H, Lin YT, Rampersaud S, Gil-Alós D, Sobh A, Dupéré-Richer D, Aleman A, Wicaksono G, Kelii KMK, Dalal R, Ramos E, Vijayanarayanan A, Lakhani K, Salangsang F, Phojanakong P, Camara Serrano JA, Zakraoui O, Tariq I, Chari A, Chung A, Kumar AD, Martin T, Wolf JL, Wong S, Steri V, Shanmugam M, Boise LH, Kortemme T, Parekh S, Stieglitz E, Licht JD, Karlon W, Barwick BG, Wiita A. PMID: 40359480.
      View in: PubMed   Mentions: 3     Fields:    Translation:HumansCells
    5. Investigating CAR-T Treatment Access for Multiple Myeloma Patients Using Real-World Evidence. medRxiv. 2025 Apr 19. Davidson J, Kumar A, Patel A, Chen IY, Butte AJ, Zack T. PMID: 40321270; PMCID: PMC12047940.
      View in: PubMed   Mentions:
    6. Role of Consolidation and Maintenance. Hematol Oncol Clin North Am. 2024 04; 38(2):421-440. Kumar AD, Chari A. PMID: 38262780.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    7. Predictors of lenalidomide maintenance duration after autologous stem cell transplant in patients with multiple myeloma. J Oncol Pharm Pract. 2023 Oct; 29(7):1715-1724. Rath C, Yoo C, Cheplowitz H, Lo M, Young R, Guglielmo J, Saunders IM, Banerjee R, Young R, Kumar A, Chung A, Rosenberg AS, Costello C, Fine J, Wilson M, Patel N, Banez MT. PMID: 36731514.
      View in: PubMed   Mentions:    Fields:    Translation:Humans
    8. Direction of Association Between Depressive Symptoms and Lifestyle Behaviors in Patients with Coronary Heart Disease: the Heart and Soul Study. Ann Behav Med. 2016 08; 50(4):523-32. Sin NL, Kumar AD, Gehi AK, Whooley MA. PMID: 26817654; PMCID: PMC4935549.
      View in: PubMed   Mentions: 37     Fields:    Translation:Humans
    Anupama's Networks
    Concepts (30)
    Derived automatically from this person's publications.
    Explore
    _
    Co-Authors (25)
    People in Profiles who have published with this person.
    Explore
    _
    Similar People (60)
    People who share similar concepts with this person.
    Explore
    _
    Same Department
    Search Department
    _

    UCSF Profiles is managed by the UCSF Clinical and Translational Science Institute (CTSI), part of the Clinical and Translational Science Award program funded by the National Center for Advancing Translational Sciences (Grant Number UL1 TR000004) at the National Institutes of Health (NIH).

    We use cookies to operate our website. We also use cookies to analyze our site’s performance and improve your experience on our site. For more information about how we use cookies, please see our Website Terms of Use. This site is running Profiles RNS version UCSF-v3.1.0-16-gff1bd585 on PROFILES-PWEB03.

    Copyright © The Regents of the University of California.